Strongbridge Biopharma
Posted on: November 1, 2018
By: Kim Berlowitz
With: Comments Off on Strongbridge Biopharma
Exclusive financial advisor to Strongbridge Biopharma on its sale of US and Canadian rights for Macrilen to Novo Nordisk